# Sozialdemokratische Partei Österreichs

<p align="center"><a href="#voting-intentions">Voting Intentions</a> | <a href="#seats">Seats</a></p>

## Voting Intentions

Last result: **21.2%** (General Election of 29 September 2019)

### Confidence Intervals

| Period     | Polling firm/Commissioner(s) | Median | 80% Confidence Interval | 90% Confidence Interval | 95% Confidence Interval | 99% Confidence Interval |
|:----------:|:----------------:|:-----------:|:-----------------------:|:-----------------------:|:-----------------------:|:-----------------------:|
| N/A | [Poll Average](average.html) | 23.6% | 20.1–26.2% | 19.4–26.8% | 18.9–27.3% | 17.9–28.4% |
| [11–12 October 2021](2021-10-12-Market.html) | Market <br> Der Standard | 25.0% | 23.1–27.0% | 22.6–27.6% | 22.1–28.1% | 21.2–29.1% |
| [7–11 October 2021](2021-10-11-IFDD.html) | IFDD | 25.0% | 23.6–26.5% | 23.3–26.9% | 22.9–27.3% | 22.3–28.0% |
| [28–30 September 2021](2021-09-30-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.9% | 19.7–24.4% | 19.1–25.1% | 18.5–25.8% | 17.5–27.0% |
| [30 August–1 September 2021](2021-09-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.8–24.5% | 19.1–25.2% | 18.6–25.8% | 17.6–27.1% |
| [24–26 August 2021](2021-08-26-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.0% | 18.8–23.5% | 18.2–24.2% | 17.6–24.8% | 16.6–26.0% |
| [17–19 August 2021](2021-08-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.0% | 18.8–23.5% | 18.2–24.2% | 17.7–24.8% | 16.7–26.0% |
| [10–12 August 2021](2021-08-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.9% | 18.8–23.4% | 18.2–24.1% | 17.6–24.7% | 16.6–25.9% |
| [6–11 August 2021](2021-08-11-Market.html) | Market <br> Der Standard | 25.0% | 23.1–27.0% | 22.6–27.6% | 22.1–28.1% | 21.2–29.1% |
| [2–5 August 2021](2021-08-05-UniqueResearch.html) | Unique Research <br> profil | 21.0% | 19.2–22.9% | 18.7–23.5% | 18.3–24.0% | 17.5–24.9% |
| [3–5 August 2021](2021-08-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.0% | 18.8–23.5% | 18.2–24.2% | 17.6–24.8% | 16.6–26.0% |
| [27–29 July 2021](2021-07-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 17.9–22.5% | 17.3–23.2% | 16.8–23.8% | 15.8–25.0% |
| [20–22 July 2021](2021-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 17.9–22.5% | 17.3–23.2% | 16.8–23.8% | 15.8–25.0% |
| [15–21 July 2021](2021-07-21-IFDD.html) | IFDD <br> PULS 24 | 22.0% | 20.2–24.0% | 19.7–24.5% | 19.3–25.0% | 18.4–26.0% |
| [13–15 July 2021](2021-07-15-ResearchAffairs.html) | Research Affairs <br> PULS | 20.0% | 18.4–21.7% | 18.0–22.2% | 17.6–22.6% | 16.9–23.4% |
| [5–8 July 2021](2021-07-08-UniqueResearch.html) | Unique Research <br> profil | 22.0% | 20.2–24.0% | 19.7–24.5% | 19.3–25.0% | 18.4–26.0% |
| [5–8 July 2021](2021-07-08-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.0% | 19.4–22.7% | 19.0–23.2% | 18.6–23.6% | 17.8–24.5% |
| [28 June–2 July 2021](2021-07-02-IFDD.html) | IFDD <br> PULS 24 | 23.9% | 22.1–26.0% | 21.6–26.5% | 21.1–27.0% | 20.3–28.0% |
| [28 June–1 July 2021](2021-07-01-UniqueResearch.html) | Unique Research <br> Heute | 22.0% | 20.2–24.0% | 19.7–24.5% | 19.3–25.0% | 18.4–26.0% |
| [28 June–1 July 2021](2021-07-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.8–24.5% | 19.2–25.2% | 18.7–25.9% | 17.6–27.1% |
| [29–30 June 2021](2021-06-30-Market.html) | Market <br> Der Standard | 26.0% | 24.1–28.0% | 23.5–28.6% | 23.1–29.1% | 22.2–30.1% |
| [22–24 June 2021](2021-06-24-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23.0% | 20.7–25.5% | 20.1–26.3% | 19.5–26.9% | 18.5–28.2% |
| [21–24 June 2021](2021-06-24-PeterHajek.html) | Peter Hajek | 23.0% | 21.2–25.0% | 20.7–25.6% | 20.2–26.0% | 19.4–27.0% |
| [22–24 June 2021](2021-06-24-OGM.html) | OGM <br> KURIER | 25.0% | 23.1–27.0% | 22.5–27.6% | 22.1–28.1% | 21.2–29.1% |
| [15–17 June 2021](2021-06-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 20.4–23.7% | 19.9–24.2% | 19.5–24.7% | 18.8–25.5% |
| [10–15 June 2021](2021-06-15-IFDD.html) | IFDD <br> PULS 24 | 27.0% | 25.1–29.1% | 24.5–29.7% | 24.1–30.2% | 23.2–31.2% |
| [7–10 June 2021](2021-06-10-UniqueResearch.html) | Unique Research <br> profil | 23.0% | 21.2–25.0% | 20.7–25.6% | 20.2–26.0% | 19.4–27.0% |
| [8–10 June 2021](2021-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.9% | 20.6–25.5% | 20.0–26.2% | 19.4–26.8% | 18.4–28.0% |
| [8–10 June 2021](2021-06-10-Market.html) | Market <br> Der Standard | 27.0% | 25.1–29.0% | 24.6–29.6% | 24.1–30.1% | 23.2–31.1% |
| [31 May–2 June 2021](2021-06-02-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23.9% | 21.6–26.5% | 21.0–27.2% | 20.4–27.8% | 19.3–29.1% |
| [24–30 May 2021](2021-05-30-Market.html) | Market | 28.0% | 26.2–29.9% | 25.7–30.4% | 25.3–30.9% | 24.5–31.8% |
| [25–27 May 2021](2021-05-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23.0% | 20.7–25.5% | 20.1–26.3% | 19.5–26.9% | 18.5–28.2% |
| [18–20 May 2021](2021-05-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.8–24.4% | 19.2–25.1% | 18.6–25.7% | 17.6–26.9% |
| [14 May 2021](2021-05-14-DemoxResearch.html) | Demox Research | 23.0% | 21.4–24.8% | 20.9–25.3% | 20.5–25.7% | 19.7–26.6% |
| [11–13 May 2021](2021-05-13-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.8–24.5% | 19.1–25.2% | 18.6–25.8% | 17.6–27.1% |
| [10–12 May 2021](2021-05-12-UniqueResearch.html) | Unique Research <br> profil | 23.0% | 21.2–25.0% | 20.7–25.6% | 20.2–26.0% | 19.4–27.0% |
| [4–6 May 2021](2021-05-06-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.0% | 18.8–23.5% | 18.2–24.2% | 17.7–24.8% | 16.7–26.0% |
| [27–29 April 2021](2021-04-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 17.8–22.4% | 17.2–23.1% | 16.7–23.7% | 15.7–24.8% |
| [26–29 April 2021](2021-04-29-PeterHajek.html) | Peter Hajek <br> APA and ATV | 25.0% | 23.1–27.0% | 22.6–27.6% | 22.1–28.1% | 21.2–29.1% |
| [20–22 April 2021](2021-04-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.9% | 18.7–23.4% | 18.1–24.1% | 17.6–24.7% | 16.6–25.9% |
| [5–8 April 2021](2021-04-08-UniqueResearch.html) | Unique Research <br> profil | 24.0% | 22.1–26.0% | 21.6–26.6% | 21.2–27.1% | 20.3–28.1% |
| [30 March–1 April 2021](2021-04-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.0% | 19.4–22.7% | 19.0–23.2% | 18.6–23.6% | 17.8–24.5% |
| [30 March–1 April 2021](2021-04-01-OGM.html) | OGM <br> KURIER | 24.0% | 22.1–26.0% | 21.6–26.6% | 21.1–27.1% | 20.3–28.0% |
| [26–30 March 2021](2021-03-30-Market.html) | Market <br> Der Standard | 26.0% | 24.1–28.1% | 23.5–28.7% | 23.1–29.2% | 22.2–30.2% |
| [23–25 March 2021](2021-03-25-UniqueResearch.html) | Unique Research <br> Heute | 23.0% | 21.2–25.0% | 20.7–25.6% | 20.2–26.0% | 19.4–27.0% |
| [23–25 March 2021](2021-03-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.7–24.5% | 19.1–25.2% | 18.5–25.8% | 17.5–27.0% |
| [15–17 March 2021](2021-03-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24.0% | 21.7–26.6% | 21.0–27.3% | 20.5–27.9% | 19.4–29.2% |
| [8–11 March 2021](2021-03-11-PeterHajek.html) | Peter Hajek <br> APA and ATV | 25.0% | 23.1–27.0% | 22.6–27.6% | 22.1–28.1% | 21.2–29.1% |
| [1–4 March 2021](2021-03-04-UniqueResearch.html) | Unique Research <br> profil | 24.0% | 22.1–26.0% | 21.6–26.6% | 21.2–27.1% | 20.3–28.1% |
| [2–4 March 2021](2021-03-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.9% | 20.7–25.5% | 20.0–26.2% | 19.5–26.8% | 18.5–28.0% |
| [15–18 February 2021](2021-02-18-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24.0% | 21.7–26.6% | 21.0–27.3% | 20.5–27.9% | 19.4–29.2% |
| [15–17 February 2021](2021-02-17-Market.html) | Market <br> Der Standard | 25.0% | 23.3–26.8% | 22.8–27.3% | 22.4–27.8% | 21.6–28.7% |
| [8–11 February 2021](2021-02-11-UniqueResearch.html) | Unique Research <br> profil | 23.0% | 21.2–25.0% | 20.7–25.6% | 20.2–26.0% | 19.4–27.0% |
| [8–11 February 2021](2021-02-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24.0% | 21.7–26.6% | 21.0–27.3% | 20.5–27.9% | 19.4–29.2% |
| [1–4 February 2021](2021-02-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24.0% | 21.7–26.6% | 21.0–27.3% | 20.5–27.9% | 19.4–29.2% |
| [25 January–1 February 2021](2021-02-01-IFDD.html) | IFDD <br> Kronen Zeitung | 24.0% | 22.1–26.0% | 21.6–26.6% | 21.2–27.1% | 20.3–28.1% |
| [11–14 January 2021](2021-01-14-UniqueResearch.html) | Unique Research <br> profil | 22.0% | 20.2–24.0% | 19.7–24.5% | 19.3–25.0% | 18.4–26.0% |
| [4–7 January 2021](2021-01-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23.0% | 21.4–24.8% | 20.9–25.3% | 20.5–25.7% | 19.7–26.6% |
| [17–21 December 2020](2020-12-21-Market.html) | Market <br> Der Standard | 23.0% | 21.2–25.0% | 20.7–25.5% | 20.2–26.0% | 19.4–27.0% |
| [15–17 December 2020](2020-12-17-OGM.html) | OGM <br> KURIER | 23.0% | 21.2–25.1% | 20.7–25.6% | 20.2–26.1% | 19.4–27.1% |
| [8–12 December 2020](2020-12-12-PeterHajek.html) | Peter Hajek <br> APA and ATV | 22.0% | 20.2–24.0% | 19.7–24.5% | 19.3–25.0% | 18.4–26.0% |
| [5 December 2020](2020-12-05-UniqueResearch.html) | Unique Research <br> profil | 20.0% | 18.3–21.9% | 17.8–22.5% | 17.4–22.9% | 16.6–23.9% |
| [30 November–3 December 2020](2020-12-03-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.8–24.5% | 19.2–25.2% | 18.7–25.9% | 17.6–27.1% |
| [30 November–2 December 2020](2020-12-02-Market.html) | Market <br> Der Standard | 23.0% | 21.2–25.0% | 20.7–25.6% | 20.2–26.0% | 19.4–27.0% |
| [17–19 November 2020](2020-11-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 19.7–24.5% | 19.1–25.2% | 18.5–25.8% | 17.5–27.0% |
| [9–12 November 2020](2020-11-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 22.0% | 20.4–23.7% | 19.9–24.2% | 19.5–24.7% | 18.8–25.5% |
| [5–7 November 2020](2020-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21.4% | 19.2–23.9% | 18.6–24.6% | 18.0–25.2% | 17.0–26.4% |
| [2–6 November 2020](2020-11-06-UniqueResearch.html) | Unique Research | 21.0% | 19.3–23.0% | 18.8–23.5% | 18.3–24.0% | 17.5–24.9% |
| [27–29 October 2020](2020-10-29-ResearchAffairs.html) | Research Affairs | 22.0% | 19.8–24.5% | 19.1–25.2% | 18.6–25.8% | 17.6–27.1% |
| [20–22 October 2020](2020-10-22-ResearchAffairs.html) | Research Affairs | 21.0% | 18.8–23.5% | 18.2–24.2% | 17.6–24.8% | 16.6–26.0% |
| [20–22 October 2020](2020-10-22-OGM.html) | OGM | 23.0% | 21.7–24.4% | 21.4–24.8% | 21.0–25.1% | 20.4–25.8% |
| [12–16 October 2020](2020-10-16-UniqueResearch.html) | Unique Research | 22.0% | 20.2–23.9% | 19.7–24.5% | 19.2–25.0% | 18.4–25.9% |
| [6–8 October 2020](2020-10-08-ResearchAffairs.html) | Research Affairs | 18.9% | 16.8–21.3% | 16.3–22.0% | 15.8–22.6% | 14.8–23.8% |
| [28–30 September 2020](2020-09-30-ResearchAffairs.html) | Research Affairs | 20.0% | 17.8–22.5% | 17.2–23.1% | 16.7–23.7% | 15.7–25.0% |
| [21–24 September 2020](2020-09-24-ResearchAffairs.html) | Research Affairs | 20.0% | 17.8–22.4% | 17.2–23.1% | 16.7–23.7% | 15.7–24.9% |
| [14–18 September 2020](2020-09-18-UniqueResearch.html) | Unique Research | 20.0% | 18.3–21.9% | 17.8–22.5% | 17.4–22.9% | 16.6–23.9% |
| [14–16 September 2020](2020-09-16-ResearchAffairs.html) | Research Affairs | 19.2% | 17.7–20.9% | 17.2–21.4% | 16.9–21.8% | 16.2–22.6% |
| [25–27 August 2020](2020-08-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 19.0% | 16.9–21.4% | 16.3–22.1% | 15.8–22.7% | 14.8–23.9% |
| [17–20 August 2020](2020-08-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 19.0% | 16.9–21.4% | 16.3–22.1% | 15.8–22.7% | 14.9–23.9% |
| [10–13 August 2020](2020-08-13-UniqueResearch.html) | Unique Research <br> profil | 18.0% | 16.3–19.8% | 15.9–20.3% | 15.5–20.8% | 14.7–21.7% |
| [20–22 July 2020](2020-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 19.0% | 16.9–21.4% | 16.3–22.1% | 15.8–22.7% | 14.8–23.9% |
| [13–16 July 2020](2020-07-16-UniqueResearch.html) | Unique Research <br> profil | 19.0% | 17.3–20.9% | 16.8–21.4% | 16.4–21.8% | 15.6–22.8% |
| [6–9 July 2020](2020-07-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.1% | 17.9–22.5% | 17.3–23.2% | 16.8–23.8% | 15.8–25.0% |
| [23–25 June 2020](2020-06-25-OGM.html) | OGM | 19.0% | 17.3–20.9% | 16.8–21.4% | 16.4–21.9% | 15.7–22.8% |
| [9–12 June 2020](2020-06-12-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.3–18.8% | 14.9–19.3% | 14.5–19.7% | 13.8–20.6% |
| [5–10 June 2020](2020-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 19.0% | 17.5–20.7% | 17.1–21.1% | 16.7–21.6% | 16.0–22.4% |
| [5–9 June 2020](2020-06-09-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 19.0% | 17.5–20.7% | 17.1–21.1% | 16.7–21.6% | 16.0–22.4% |
| [25–28 May 2020](2020-05-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 18.0% | 16.5–19.6% | 16.1–20.1% | 15.7–20.5% | 15.0–21.3% |
| [21–26 May 2020](2020-05-26-Market.html) | Market <br> Der Standard | 20.0% | 18.3–21.9% | 17.8–22.5% | 17.4–22.9% | 16.6–23.9% |
| [18–19 May 2020](2020-05-19-Market.html) | Market <br> Der Standard | 21.0% | 19.4–22.7% | 19.0–23.2% | 18.6–23.6% | 17.8–24.5% |
| [11–14 May 2020](2020-05-14-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.3–18.8% | 14.9–19.3% | 14.5–19.7% | 13.8–20.6% |
| [11–13 May 2020](2020-05-13-Market.html) | Market <br> Der Standard | 21.0% | 19.4–22.7% | 19.0–23.2% | 18.6–23.6% | 17.8–24.5% |
| [20–22 April 2020](2020-04-22-Market.html) | Market | 20.0% | 18.4–21.7% | 18.0–22.2% | 17.6–22.6% | 16.9–23.4% |
| [13–16 April 2020](2020-04-16-UniqueResearch.html) | Unique Research <br> profil | 16.0% | 14.4–17.8% | 14.0–18.3% | 13.6–18.7% | 12.9–19.6% |
| [3–7 April 2020](2020-04-07-Market.html) | Market <br> Der Standard | 19.0% | 17.8–20.2% | 17.5–20.6% | 17.3–20.9% | 16.7–21.5% |
| [31 March–2 April 2020](2020-04-02-OGM.html) | OGM | 16.0% | 14.4–17.8% | 14.0–18.3% | 13.6–18.7% | 12.9–19.6% |
| [24–31 March 2020](2020-03-31-Market.html) | Market <br> Der Standard | 19.0% | 17.5–20.7% | 17.1–21.1% | 16.7–21.6% | 16.0–22.4% |
| [9–13 March 2020](2020-03-13-UniqueResearch.html) | Unique Research | 16.0% | 14.5–17.8% | 14.0–18.3% | 13.7–18.7% | 12.9–19.6% |
| [11–12 March 2020](2020-03-12-Market.html) | Market <br> Der Standard | 20.0% | 18.4–21.7% | 18.0–22.2% | 17.6–22.6% | 16.9–23.4% |
| [5–11 March 2020](2020-03-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.4% | 15.9–19.0% | 15.5–19.4% | 15.1–19.8% | 14.5–20.6% |
| [24–27 February 2020](2020-02-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.1% | 15.7–18.8% | 15.3–19.2% | 14.9–19.6% | 14.3–20.4% |
| [10–14 February 2020](2020-02-14-UniqueResearch.html) | Unique Research <br> profil | 15.0% | 13.5–16.8% | 13.1–17.3% | 12.7–17.7% | 12.0–18.5% |
| [7–12 February 2020](2020-02-12-ResearchAffairs.html) | Research Affairs | 18.0% | 16.2–20.0% | 15.7–20.6% | 15.3–21.1% | 14.4–22.1% |
| [4–6 February 2020](2020-02-06-Market.html) | Market | 18.9% | 17.3–20.8% | 16.8–21.3% | 16.4–21.8% | 15.6–22.7% |
| [28–31 January 2020](2020-01-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.0–19.3% | 14.4–20.0% | 14.0–20.5% | 13.0–21.7% |
| [17–23 January 2020](2020-01-23-ResearchAffairs.html) | Research Affairs | 16.0% | 14.5–17.6% | 14.0–18.1% | 13.7–18.5% | 13.0–19.4% |
| [10–16 January 2020](2020-01-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.6–17.5% | 14.2–18.0% | 13.8–18.4% | 13.2–19.1% |
| [10–15 January 2020](2020-01-15-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 17.0% | 15.5–18.6% | 15.1–19.1% | 14.8–19.5% | 14.1–20.3% |
| [6–10 January 2020](2020-01-10-UniqueResearch.html) | Unique Research <br> profil | 16.0% | 14.4–17.8% | 14.0–18.3% | 13.6–18.7% | 12.9–19.6% |
| [3–9 January 2020](2020-01-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.4–18.7% | 15.0–19.2% | 14.6–19.7% | 13.9–20.5% |
| [12–19 December 2019](2019-12-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.5–18.7% | 15.0–19.2% | 14.6–19.6% | 13.9–20.5% |
| [16–19 December 2019](2019-12-19-Market.html) | Market <br> Der Standard | 19.0% | 17.3–20.9% | 16.8–21.4% | 16.4–21.8% | 15.6–22.8% |
| [9–13 December 2019](2019-12-13-UniqueResearch.html) | Unique Research <br> profil | 18.0% | 16.3–19.8% | 15.9–20.3% | 15.5–20.8% | 14.7–21.7% |
| [6–12 December 2019](2019-12-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.5–18.8% | 15.0–19.3% | 14.7–19.7% | 14.0–20.5% |
| [29 November–5 December 2019](2019-12-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.4–18.7% | 14.9–19.2% | 14.6–19.7% | 13.8–20.5% |
| [29 November–4 December 2019](2019-12-04-Market.html) | Market <br> Der Standard | 18.1% | 16.4–19.9% | 15.9–20.4% | 15.5–20.9% | 14.8–21.8% |
| [22–28 November 2019](2019-11-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 18.0% | 16.4–19.8% | 16.0–20.3% | 15.6–20.7% | 14.8–21.6% |
| [15–21 November 2019](2019-11-21-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 18.4–21.9% | 17.9–22.4% | 17.5–22.8% | 16.8–23.7% |
| [11–15 November 2019](2019-11-15-UniqueResearch.html) | Unique Research <br> profil | 19.0% | 17.3–20.8% | 16.8–21.4% | 16.4–21.8% | 15.7–22.7% |
| [8–14 November 2019](2019-11-14-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 18.3–21.9% | 17.9–22.4% | 17.5–22.9% | 16.7–23.8% |
| [8–13 November 2019](2019-11-13-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 20.0% | 19.1–21.0% | 18.8–21.2% | 18.6–21.5% | 18.2–21.9% |
| [2–7 November 2019](2019-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 18.4–21.7% | 18.0–22.1% | 17.6–22.6% | 16.9–23.4% |
| [26–31 October 2019](2019-10-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 19.0% | 17.3–20.9% | 16.9–21.5% | 16.4–21.9% | 15.7–22.9% |
| [22–25 October 2019](2019-10-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 19.0% | 17.5–20.7% | 17.1–21.1% | 16.7–21.6% | 16.0–22.4% |
| [14–19 October 2019](2019-10-19-Market.html) | Market <br> Der Standard | 20.0% | 18.2–21.9% | 17.7–22.4% | 17.3–22.9% | 16.5–23.8% |
| [15–17 October 2019](2019-10-17-Market.html) | Market <br> Der Standard | 20.0% | 18.2–21.9% | 17.7–22.4% | 17.3–22.9% | 16.5–23.8% |
| [10–16 October 2019](2019-10-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20.0% | 18.4–21.7% | 18.0–22.2% | 17.6–22.6% | 16.9–23.4% |
| [7–11 October 2019](2019-10-11-UniqueResearch.html) | Unique Research <br> profil | 20.0% | 18.2–21.9% | 17.7–22.4% | 17.3–22.9% | 16.5–23.8% |

### Probability Mass Function

The following table shows the probability mass function per percentage block of voting intentions for the [poll average](average.html) for Sozialdemokratische Partei Österreichs.

| Voting Intentions | Probability | Accumulated | Special Marks |
|:-----------------:|:-----------:|:-----------:|:-------------:|
| 15.5–16.5% | 0% | 100% |  |
| 16.5–17.5% | 0.2% | 100% |  |
| 17.5–18.5% | 1.3% | 99.7% |  |
| 18.5–19.5% | 4% | 98% |  |
| 19.5–20.5% | 9% | 94% |  |
| 20.5–21.5% | 12% | 86% | Last Result |
| 21.5–22.5% | 12% | 74% |  |
| 22.5–23.5% | 12% | 62% |  |
| 23.5–24.5% | 15% | 50% | Median |
| 24.5–25.5% | 17% | 35% |  |
| 25.5–26.5% | 12% | 18% |  |
| 26.5–27.5% | 5% | 7% |  |
| 27.5–28.5% | 1.4% | 2% |  |
| 28.5–29.5% | 0.3% | 0.4% |  |
| 29.5–30.5% | 0.1% | 0.1% |  |
| 30.5–31.5% | 0% | 0% |  |


## Seats

Last result: **40** seats (General Election of 29 September 2019)

### Confidence Intervals

| Period     | Polling firm/Commissioner(s) | Median | 80% Confidence Interval | 90% Confidence Interval | 95% Confidence Interval | 99% Confidence Interval |
|:----------:|:----------------:|:------:|:-----------------------:|:-----------------------:|:-----------------------:|:-----------------------:|
| N/A | [Poll Average](average.html) | 44 | 37–49 | 36–50 | 35–51 | 33–53 |
| [11–12 October 2021](2021-10-12-Market.html) | Market <br> Der Standard | 47 | 43–51 | 42–52 | 41–53 | 40–55 |
| [7–11 October 2021](2021-10-11-IFDD.html) | IFDD | 46 | 43–49 | 43–49 | 42–50 | 41–51 |
| [28–30 September 2021](2021-09-30-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 41 | 37–46 | 36–48 | 35–49 | 33–52 |
| [30 August–1 September 2021](2021-09-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 41 | 37–46 | 36–47 | 35–48 | 33–51 |
| [24–26 August 2021](2021-08-26-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 35–44 | 33–45 | 33–46 | 31–49 |
| [17–19 August 2021](2021-08-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 34–44 | 33–45 | 32–46 | 31–49 |
| [10–12 August 2021](2021-08-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 38 | 34–43 | 33–44 | 32–45 | 30–48 |
| [6–11 August 2021](2021-08-11-Market.html) | Market <br> Der Standard | 47 | 43–50 | 42–51 | 41–52 | 39–54 |
| [2–5 August 2021](2021-08-05-UniqueResearch.html) | Unique Research <br> profil | 39 | 36–43 | 35–44 | 34–45 | 33–46 |
| [3–5 August 2021](2021-08-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 35–44 | 33–45 | 32–46 | 31–49 |
| [27–29 July 2021](2021-07-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37 | 33–42 | 32–43 | 31–44 | 29–46 |
| [20–22 July 2021](2021-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37 | 33–42 | 32–43 | 31–44 | 29–46 |
| [15–21 July 2021](2021-07-21-IFDD.html) | IFDD <br> PULS 24 | 41 | 37–44 | 36–45 | 35–46 | 34–48 |
| [13–15 July 2021](2021-07-15-ResearchAffairs.html) | Research Affairs <br> PULS | 37 | 34–41 | 33–42 | 32–42 | 31–44 |
| [5–8 July 2021](2021-07-08-UniqueResearch.html) | Unique Research <br> profil | 41 | 38–45 | 37–46 | 36–47 | 34–49 |
| [5–8 July 2021](2021-07-08-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 36–42 | 35–44 | 34–45 | 33–46 |
| [28 June–2 July 2021](2021-07-02-IFDD.html) | IFDD <br> PULS 24 | 43 | 40–47 | 39–48 | 38–50 | 37–52 |
| [28 June–1 July 2021](2021-07-01-UniqueResearch.html) | Unique Research <br> Heute | 41 | 37–44 | 36–45 | 35–46 | 34–48 |
| [28 June–1 July 2021](2021-07-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 41 | 36–45 | 35–47 | 34–48 | 32–50 |
| [29–30 June 2021](2021-06-30-Market.html) | Market <br> Der Standard | 49 | 45–52 | 44–53 | 43–54 | 41–56 |
| [22–24 June 2021](2021-06-24-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 43 | 38–47 | 37–49 | 36–50 | 34–53 |
| [21–24 June 2021](2021-06-24-PeterHajek.html) | Peter Hajek | 43 | 39–47 | 38–48 | 38–49 | 36–50 |
| [22–24 June 2021](2021-06-24-OGM.html) | OGM <br> KURIER | 47 | 43–50 | 42–52 | 41–53 | 40–54 |
| [15–17 June 2021](2021-06-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 40 | 37–44 | 36–45 | 36–45 | 34–47 |
| [10–15 June 2021](2021-06-15-IFDD.html) | IFDD <br> PULS 24 | 50 | 46–54 | 45–55 | 44–56 | 43–58 |
| [7–10 June 2021](2021-06-10-UniqueResearch.html) | Unique Research <br> profil | 43 | 39–47 | 38–48 | 38–49 | 36–50 |
| [8–10 June 2021](2021-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 42 | 38–47 | 37–48 | 35–50 | 34–52 |
| [8–10 June 2021](2021-06-10-Market.html) | Market <br> Der Standard | 50 | 46–54 | 45–55 | 44–56 | 43–57 |
| [31 May–2 June 2021](2021-06-02-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 45 | 41–50 | 39–51 | 38–52 | 36–54 |
| [24–30 May 2021](2021-05-30-Market.html) | Market | 52 | 49–56 | 48–57 | 47–58 | 46–59 |
| [25–27 May 2021](2021-05-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 43 | 38–48 | 37–49 | 36–50 | 34–53 |
| [18–20 May 2021](2021-05-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 41 | 36–46 | 35–47 | 34–48 | 32–50 |
| [14 May 2021](2021-05-14-DemoxResearch.html) | Demox Research | 43 | 40–47 | 39–48 | 38–48 | 37–50 |
| [11–13 May 2021](2021-05-13-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 41 | 37–46 | 36–47 | 35–48 | 33–51 |
| [10–12 May 2021](2021-05-12-UniqueResearch.html) | Unique Research <br> profil | 43 | 40–47 | 39–48 | 38–49 | 36–51 |
| [4–6 May 2021](2021-05-06-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 35–44 | 34–45 | 33–46 | 31–49 |
| [27–29 April 2021](2021-04-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37 | 33–41 | 32–43 | 31–44 | 29–46 |
| [26–29 April 2021](2021-04-29-PeterHajek.html) | Peter Hajek <br> APA and ATV | 47 | 43–50 | 42–51 | 41–53 | 40–54 |
| [20–22 April 2021](2021-04-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 34–43 | 33–45 | 32–46 | 30–48 |
| [5–8 April 2021](2021-04-08-UniqueResearch.html) | Unique Research <br> profil | 45 | 41–49 | 40–50 | 39–51 | 38–52 |
| [30 March–1 April 2021](2021-04-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 39 | 36–43 | 35–43 | 34–44 | 33–46 |
| [30 March–1 April 2021](2021-04-01-OGM.html) | OGM <br> KURIER | 45 | 41–49 | 40–50 | 40–51 | 38–53 |
| [26–30 March 2021](2021-03-30-Market.html) | Market <br> Der Standard | 48 | 44–52 | 43–53 | 43–54 | 41–56 |
| [23–25 March 2021](2021-03-25-UniqueResearch.html) | Unique Research <br> Heute | 42 | 39–46 | 38–47 | 37–48 | 36–50 |
| [23–25 March 2021](2021-03-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 40 | 36–45 | 35–46 | 34–47 | 32–50 |
| [15–17 March 2021](2021-03-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 44 | 40–49 | 38–51 | 37–52 | 36–55 |
| [8–11 March 2021](2021-03-11-PeterHajek.html) | Peter Hajek <br> APA and ATV | 47 | 43–50 | 42–52 | 41–53 | 40–54 |
| [1–4 March 2021](2021-03-04-UniqueResearch.html) | Unique Research <br> profil | 45 | 41–49 | 40–50 | 39–51 | 38–52 |
| [2–4 March 2021](2021-03-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 43 | 38–47 | 37–49 | 36–50 | 34–52 |
| [15–18 February 2021](2021-02-18-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 45 | 40–50 | 39–51 | 38–52 | 36–55 |
| [15–17 February 2021](2021-02-17-Market.html) | Market <br> Der Standard | 47 | 43–50 | 43–51 | 42–52 | 40–54 |
| [8–11 February 2021](2021-02-11-UniqueResearch.html) | Unique Research <br> profil | 43 | 40–47 | 39–48 | 38–49 | 36–51 |
| [8–11 February 2021](2021-02-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 45 | 40–50 | 39–51 | 38–52 | 36–55 |
| [1–4 February 2021](2021-02-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 45 | 40–50 | 39–51 | 38–52 | 36–55 |
| [25 January–1 February 2021](2021-02-01-IFDD.html) | IFDD <br> Kronen Zeitung | 45 | 41–49 | 40–50 | 39–51 | 38–52 |
| [11–14 January 2021](2021-01-14-UniqueResearch.html) | Unique Research <br> profil | 41 | 37–44 | 36–45 | 35–46 | 34–48 |
| [4–7 January 2021](2021-01-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 43 | 39–46 | 39–47 | 38–48 | 36–50 |
| [17–21 December 2020](2020-12-21-Market.html) | Market <br> Der Standard | 43 | 40–47 | 38–48 | 38–49 | 36–50 |
| [15–17 December 2020](2020-12-17-OGM.html) | OGM <br> KURIER | 43 | 40–47 | 39–48 | 38–49 | 36–50 |
| [8–12 December 2020](2020-12-12-PeterHajek.html) | Peter Hajek <br> APA and ATV | 41 | 37–44 | 36–45 | 35–46 | 34–48 |
| [5 December 2020](2020-12-05-UniqueResearch.html) | Unique Research <br> profil | 37 | 34–41 | 33–42 | 32–43 | 31–44 |
| [30 November–3 December 2020](2020-12-03-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 42 | 38–47 | 36–48 | 35–49 | 33–51 |
| [30 November–2 December 2020](2020-12-02-Market.html) | Market <br> Der Standard | 43 | 39–47 | 38–48 | 38–49 | 36–50 |
| [17–19 November 2020](2020-11-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 42 | 37–47 | 36–48 | 35–49 | 33–51 |
| [9–12 November 2020](2020-11-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 42 | 39–45 | 38–46 | 37–47 | 36–49 |
| [5–7 November 2020](2020-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 40 | 36–45 | 35–47 | 34–48 | 32–50 |
| [2–6 November 2020](2020-11-06-UniqueResearch.html) | Unique Research | 40 | 36–43 | 35–44 | 34–45 | 33–47 |
| [27–29 October 2020](2020-10-29-ResearchAffairs.html) | Research Affairs | 42 | 37–47 | 36–48 | 35–50 | 33–52 |
| [20–22 October 2020](2020-10-22-ResearchAffairs.html) | Research Affairs | 40 | 35–45 | 34–46 | 33–47 | 31–50 |
| [20–22 October 2020](2020-10-22-OGM.html) | OGM | 43 | 40–46 | 40–46 | 39–47 | 38–48 |
| [12–16 October 2020](2020-10-16-UniqueResearch.html) | Unique Research | 41 | 38–45 | 37–46 | 36–47 | 34–49 |
| [6–8 October 2020](2020-10-08-ResearchAffairs.html) | Research Affairs | 35 | 31–40 | 30–41 | 29–42 | 28–44 |
| [28–30 September 2020](2020-09-30-ResearchAffairs.html) | Research Affairs | 37 | 33–42 | 32–43 | 31–45 | 29–47 |
| [21–24 September 2020](2020-09-24-ResearchAffairs.html) | Research Affairs | 38 | 33–42 | 32–44 | 31–45 | 29–47 |
| [14–18 September 2020](2020-09-18-UniqueResearch.html) | Unique Research | 37 | 34–40 | 33–41 | 32–42 | 30–44 |
| [14–16 September 2020](2020-09-16-ResearchAffairs.html) | Research Affairs | 35 | 32–38 | 31–39 | 31–40 | 29–42 |
| [25–27 August 2020](2020-08-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36 | 31–40 | 30–41 | 29–43 | 27–45 |
| [17–20 August 2020](2020-08-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35 | 32–40 | 30–42 | 29–42 | 27–45 |
| [10–13 August 2020](2020-08-13-UniqueResearch.html) | Unique Research <br> profil | 33 | 30–36 | 29–37 | 28–38 | 27–40 |
| [20–22 July 2020](2020-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36 | 31–40 | 30–41 | 29–43 | 27–45 |
| [13–16 July 2020](2020-07-16-UniqueResearch.html) | Unique Research <br> profil | 35 | 32–38 | 31–39 | 30–40 | 29–42 |
| [6–9 July 2020](2020-07-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 40 | 33–44 | 32–45 | 31–46 | 30–47 |
| [23–25 June 2020](2020-06-25-OGM.html) | OGM | 35 | 32–39 | 31–40 | 30–41 | 29–42 |
| [9–12 June 2020](2020-06-12-UniqueResearch.html) | Unique Research <br> profil | 31 | 28–35 | 27–35 | 27–36 | 25–38 |
| [5–10 June 2020](2020-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36 | 33–39 | 32–40 | 32–41 | 30–42 |
| [5–9 June 2020](2020-06-09-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 36 | 33–39 | 32–40 | 31–41 | 30–42 |
| [25–28 May 2020](2020-05-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 34 | 31–37 | 30–38 | 30–39 | 28–40 |
| [21–26 May 2020](2020-05-26-Market.html) | Market <br> Der Standard | 37 | 34–40 | 33–41 | 32–42 | 30–44 |
| [18–19 May 2020](2020-05-19-Market.html) | Market <br> Der Standard | 39 | 36–42 | 35–43 | 34–44 | 33–45 |
| [11–14 May 2020](2020-05-14-UniqueResearch.html) | Unique Research <br> profil | 32 | 29–35 | 28–36 | 27–37 | 26–38 |
| [11–13 May 2020](2020-05-13-Market.html) | Market <br> Der Standard | 39 | 36–42 | 35–43 | 34–44 | 33–45 |
| [20–22 April 2020](2020-04-22-Market.html) | Market | 37 | 34–40 | 33–41 | 32–42 | 31–43 |
| [13–16 April 2020](2020-04-16-UniqueResearch.html) | Unique Research <br> profil | 29 | 26–33 | 26–34 | 25–34 | 24–36 |
| [3–7 April 2020](2020-04-07-Market.html) | Market <br> Der Standard | 35 | 33–37 | 32–38 | 32–39 | 31–40 |
| [31 March–2 April 2020](2020-04-02-OGM.html) | OGM | 30 | 27–33 | 26–34 | 25–35 | 24–36 |
| [24–31 March 2020](2020-03-31-Market.html) | Market <br> Der Standard | 35 | 32–38 | 31–39 | 31–40 | 29–41 |
| [9–13 March 2020](2020-03-13-UniqueResearch.html) | Unique Research | 30 | 27–33 | 26–34 | 25–35 | 24–37 |
| [11–12 March 2020](2020-03-12-Market.html) | Market <br> Der Standard | 37 | 34–40 | 33–41 | 32–42 | 31–43 |
| [5–11 March 2020](2020-03-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 29–35 | 29–36 | 28–37 | 27–39 |
| [24–27 February 2020](2020-02-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31 | 29–34 | 28–35 | 27–36 | 26–37 |
| [10–14 February 2020](2020-02-14-UniqueResearch.html) | Unique Research <br> profil | 28 | 25–31 | 24–32 | 23–33 | 22–35 |
| [7–12 February 2020](2020-02-12-ResearchAffairs.html) | Research Affairs | 33 | 30–37 | 29–38 | 28–39 | 26–41 |
| [4–6 February 2020](2020-02-06-Market.html) | Market | 35 | 32–38 | 31–39 | 30–40 | 29–42 |
| [28–31 January 2020](2020-01-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 27–36 | 26–37 | 26–38 | 24–40 |
| [17–23 January 2020](2020-01-23-ResearchAffairs.html) | Research Affairs | 30 | 27–33 | 26–34 | 25–35 | 24–36 |
| [10–16 January 2020](2020-01-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 29 | 27–32 | 26–33 | 25–34 | 24–35 |
| [10–15 January 2020](2020-01-15-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 32 | 29–35 | 28–36 | 28–37 | 26–38 |
| [6–10 January 2020](2020-01-10-UniqueResearch.html) | Unique Research <br> profil | 30 | 27–33 | 26–34 | 25–35 | 24–37 |
| [3–9 January 2020](2020-01-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31 | 28–34 | 27–35 | 27–36 | 25–38 |
| [12–19 December 2019](2019-12-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 28–35 | 28–36 | 27–37 | 26–38 |
| [16–19 December 2019](2019-12-19-Market.html) | Market <br> Der Standard | 35 | 32–39 | 31–40 | 30–41 | 29–42 |
| [9–13 December 2019](2019-12-13-UniqueResearch.html) | Unique Research <br> profil | 33 | 30–36 | 29–37 | 28–38 | 27–40 |
| [6–12 December 2019](2019-12-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31 | 28–34 | 27–35 | 27–36 | 25–38 |
| [29 November–5 December 2019](2019-12-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31 | 28–35 | 27–36 | 27–37 | 25–38 |
| [29 November–4 December 2019](2019-12-04-Market.html) | Market <br> Der Standard | 34 | 30–37 | 30–38 | 29–39 | 27–41 |
| [22–28 November 2019](2019-11-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33 | 30–37 | 29–38 | 29–39 | 27–40 |
| [15–21 November 2019](2019-11-21-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 38 | 34–41 | 34–42 | 33–43 | 31–45 |
| [11–15 November 2019](2019-11-15-UniqueResearch.html) | Unique Research <br> profil | 35 | 32–38 | 31–39 | 30–40 | 29–42 |
| [8–14 November 2019](2019-11-14-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37 | 35–41 | 33–42 | 32–43 | 31–44 |
| [8–13 November 2019](2019-11-13-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 38 | 36–40 | 35–40 | 35–41 | 34–41 |
| [2–7 November 2019](2019-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 38 | 34–41 | 34–42 | 33–42 | 32–44 |
| [26–31 October 2019](2019-10-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 36 | 32–39 | 32–40 | 31–41 | 29–43 |
| [22–25 October 2019](2019-10-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 35 | 32–39 | 31–40 | 31–40 | 29–42 |
| [14–19 October 2019](2019-10-19-Market.html) | Market <br> Der Standard | 37 | 34–41 | 33–42 | 32–43 | 31–44 |
| [15–17 October 2019](2019-10-17-Market.html) | Market <br> Der Standard | 37 | 34–41 | 33–42 | 32–43 | 31–44 |
| [10–16 October 2019](2019-10-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 37 | 34–40 | 33–41 | 32–42 | 31–44 |
| [7–11 October 2019](2019-10-11-UniqueResearch.html) | Unique Research <br> profil | 37 | 34–41 | 33–42 | 32–43 | 31–44 |

### Probability Mass Function

![Graph with seats probability mass function not yet produced](average-seats-pmf-sozialdemokratischeparteiösterreichs.png "Seats Probability Mass Function")

The following table shows the probability mass function per seat for the [poll average](average.html) for Sozialdemokratische Partei Österreichs.

| Number of Seats | Probability | Accumulated | Special Marks |
|:---------------:|:-----------:|:-----------:|:-------------:|
| 31 | 0.1% | 100% |  |
| 32 | 0.2% | 99.9% |  |
| 33 | 0.4% | 99.8% |  |
| 34 | 0.8% | 99.3% |  |
| 35 | 2% | 98% |  |
| 36 | 3% | 97% |  |
| 37 | 4% | 94% |  |
| 38 | 5% | 90% |  |
| 39 | 6% | 85% |  |
| 40 | 7% | 79% | Last Result |
| 41 | 6% | 72% |  |
| 42 | 6% | 66% |  |
| 43 | 7% | 60% |  |
| 44 | 8% | 53% | Median |
| 45 | 8% | 45% |  |
| 46 | 11% | 37% |  |
| 47 | 8% | 26% |  |
| 48 | 6% | 18% |  |
| 49 | 5% | 12% |  |
| 50 | 4% | 7% |  |
| 51 | 1.3% | 3% |  |
| 52 | 0.9% | 2% |  |
| 53 | 0.7% | 1.1% |  |
| 54 | 0.2% | 0.4% |  |
| 55 | 0.1% | 0.2% |  |
| 56 | 0.1% | 0.1% |  |
| 57 | 0% | 0% |  |


